Aussie clinical trials growth
April 18, 2012
THE number of clinical trials
undertaken in Australia has grown
for the first time in four years,
according to new figures from the
Therapeutic Goods Administration.
The TGA’s latest Half-Yearly
Performance Report found that in
2011 there were 635 new clinical
trials started in Australia, up by 61
from 574 in 2010.
This number however, is still
down by 25% from the 2007 high of
865 trials in Australia.
Speaking in the wake of the
figures, Medicines Australia Chief
Executive Dr Brendan Shaw
welcomed the upturn saying it was
“encouraging”.
Shaw however stopped short of
wholly praising the rise saying that
there remained serious challenges
to Australia’s status as a regional
hub for clinical trials.
“The latest figures don’t alleviate
the need for urgent policy action to
drive microeconomic and
regulatory reform to secure the
future of clinical trials in Australia,”
Shaw said.
“The Government’s commitment
last year to a series of regulatory
reforms to increase Australia’s
competitiveness as a destination
for clinical trials may have
encouraged some investment over
the past year.
“But there has been insufficient
progress in implementing these
regulatory reforms,” he added.
Shaw called on the Government
to expeditiously implement the
regulatory reforms, saying that the
nation must act now to ensure it
remains competitive.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Apr 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Apr 12
